CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-25 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise | +6,178 | 63,477 | ||
| 2026-03-25 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −6,178 | 12,358 | ||
| 2026-03-25 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | Sale | −3,435 | $21.47 | $74K | 3,280 |
| 2026-03-25 | Owen Adams Catherine Chief Executive Officer | Sale | −11,641 | $21.47 | $250K | 14,803 |
| 2026-03-25 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Sale | −833 | $21.47 | $18K | 25,852 |
| 2026-03-25 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise | +2,142 | 27,994 | ||
| 2026-03-25 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | −2,142 | 4,284 | ||
| 2026-03-25 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Sale | −3,844 | $21.47 | $83K | 11,280 |
| 2026-03-24 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise | +8,138 | 61,476 | ||
| 2026-03-24 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −8,138 | 24,414 | ||
| 2026-03-24 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | Option exercise | +6,715 | 6,715 | ||
| 2026-03-24 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | Option exercise · Restricted Stock Units | −6,715 | 20,146 | ||
| 2026-03-24 | Owen Adams Catherine Chief Executive Officer | Option exercise | +23,509 | 26,444 | ||
| 2026-03-24 | Owen Adams Catherine Chief Executive Officer | Option exercise · Restricted Stock Units | −23,509 | 70,530 | ||
| 2026-03-24 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise | +1,627 | 26,685 | ||
| 2026-03-24 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | −1,627 | 4,883 | ||
| 2026-03-24 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Option exercise | +7,515 | 15,124 | ||
| 2026-03-24 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Option exercise · Restricted Stock Units | −7,515 | 22,547 | ||
| 2026-03-06 | Garner Thomas EVP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +97,947 | 97,947 | ||
| 2026-03-06 | Garner Thomas EVP, Chief Commercial Officer | Grant or award · Restricted Stock Units | +28,493 | 28,493 |
Page 4 of 49 · 979 trades